Contemporary anticoagulant treatment strategies in patients with acute pulmonary embolism at different risk for death

CONCLUSIONS: Contemporary anticoagulation for acute PE includes parenteral agents in over 90% of patients; DOACs are used in the large majority of PE patients at discharge and their early use seems effective and safe also in selected intermediate-risk patients.TRIAL REGISTRATION NUMBER: NCT03631810.PMID:38013135 | DOI:10.1016/j.vph.2023.107245

Source: Vascular Pharmacology - November 28, 2023 Category: Drugs & Pharmacology Authors: Cecilia Becattini Giancarlo Agnelli Michele Diamanti Aldo P Maggioni Simone Vanni Francesco Dentali Iolanda Enea Paola Bortolotti Massimiliano De Vecchi Nicola Artusi Claudio Picariello Cinzia Nitti Donata Lucci Michele M Gulizia COPE Investigators Source Type: research